摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(5-Fluoro-2-pyridin-2-ylbenzimidazol-1-yl)phenol | 1067911-97-0

中文名称
——
中文别名
——
英文名称
4-(5-Fluoro-2-pyridin-2-ylbenzimidazol-1-yl)phenol
英文别名
——
4-(5-Fluoro-2-pyridin-2-ylbenzimidazol-1-yl)phenol化学式
CAS
1067911-97-0
化学式
C18H12FN3O
mdl
——
分子量
305.311
InChiKey
MGLVTVFJNGJIOC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    23
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    50.9
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    4-(5-Fluoro-2-pyridin-2-ylbenzimidazol-1-yl)phenol1-溴-3-氯丙烷potassium carbonate 作用下, 以 丙酮 为溶剂, 反应 20.67h, 以93%的产率得到1-[4-(3-Chloropropoxy)phenyl]-5-fluoro-2-pyridin-2-ylbenzimidazole
    参考文献:
    名称:
    Benzimidazole-substituted (3-phenoxypropyl)amines as histamine H3 receptor ligands
    摘要:
    A series of non-imidazole histamine H-3 receptor antagonists based on the (3-phenoxypropyl)amine motif, which is a common pharmacophore for H-3 antagonists, has been identified. A preliminary SAR study around the amine moiety has identified 8a as a potent H-3 antagonist possessing a good pharmacokinetic profile in the rat. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.08.008
  • 作为产物:
    描述:
    N-[5-fluoro-2-(4-hydroxyanilino)phenyl]pyridine-2-carboxamide溶剂黄146 作用下, 反应 20.0h, 以100%的产率得到4-(5-Fluoro-2-pyridin-2-ylbenzimidazol-1-yl)phenol
    参考文献:
    名称:
    Imidazole and benzimidazole derivatives useful as histamine H3 antagonists
    摘要:
    揭示了以下公式化合物或其药学上可接受的盐或溶剂,其中:n为2-5;R为R3-芳基,R3-杂环芳基,R3-环烷基,R3-杂环烷基,烷基,卤代烷基,—OR4,—SR4或—S(O)1-2R5;R1和R2为H或可选择地取代的苯基或可选择地取代的,X为—O—或—S—;或R1和R2,连同它们连接的碳原子形成可选择地取代的,X为—O—,—S—或—NR7—;Z为,其余变量如规范中所定义;还揭示了包括公式I化合物的药物组合物;还揭示了使用公式I化合物治疗过敏、过敏引起的气道反应、充血、肥胖和代谢综合征的方法,以及与其他用于治疗这些疾病的药物的组合。
    公开号:
    US20060166960A1
点击查看最新优质反应信息

文献信息

  • Imidazole and benzimidazole derivatives useful as histamine H3 antagonists
    申请人:Aslanian G. Robert
    公开号:US20060166960A1
    公开(公告)日:2006-07-27
    Disclosed are compounds of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein: n is 2-5; R is R 3 -aryl, R 3 -heteroaryl, R 3 -cycloalkyl, R 3 -heterocycloalkyl, alkyl, haloalkyl, —OR 4 , —SR 4 or —S(O) 1-2 R 5 ; R 1 and R 2 are H or optionally substituted phenyl or optionally substituted and X is —O— or —S—; or R 1 and R 2 , together with the carbon atoms to which they are attached form optionally substituted and X is —O—, —S— or —NR 7 —; Z is and the remaining variables are as defined in the specification; also disclosed are pharmaceutical compositions comprising the compounds of formula I; also disclosed are methods of treating allergy, allergy-induced airway responses, congestion, obesity and metabolic syndrome using the compounds of Formula I, as well as combinations with other drugs useful for treating those diseases.
    揭示了以下公式化合物或其药学上可接受的盐或溶剂,其中:n为2-5;R为R3-芳基,R3-杂环芳基,R3-环烷基,R3-杂环烷基,烷基,卤代烷基,—OR4,—SR4或—S(O)1-2R5;R1和R2为H或可选择地取代的苯基或可选择地取代的,X为—O—或—S—;或R1和R2,连同它们连接的碳原子形成可选择地取代的,X为—O—,—S—或—NR7—;Z为,其余变量如规范中所定义;还揭示了包括公式I化合物的药物组合物;还揭示了使用公式I化合物治疗过敏、过敏引起的气道反应、充血、肥胖和代谢综合征的方法,以及与其他用于治疗这些疾病的药物的组合。
  • US7482468B2
    申请人:——
    公开号:US7482468B2
    公开(公告)日:2009-01-27
  • Benzimidazole-substituted (3-phenoxypropyl)amines as histamine H3 receptor ligands
    作者:Robert Aslanian、Xiaohong Zhu、Henry A. Vaccaro、Neng-Yang Shih、John J. Piwinski、Shirley M. Williams、Robert E. West
    DOI:10.1016/j.bmcl.2008.08.008
    日期:2008.9
    A series of non-imidazole histamine H-3 receptor antagonists based on the (3-phenoxypropyl)amine motif, which is a common pharmacophore for H-3 antagonists, has been identified. A preliminary SAR study around the amine moiety has identified 8a as a potent H-3 antagonist possessing a good pharmacokinetic profile in the rat. (C) 2008 Elsevier Ltd. All rights reserved.
查看更多